Skip to content
Screener

Baxter International BAX Total Cost of Revenue

Total Cost of Revenue at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.67B-7.2%
Stryker logo
StrykerSYK
$2.09B-4.1%
KORU Medical Systems logo
KORU Medical SystemsKRMD
$4.2M+12.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$346.1M+7.1%
Axogen logo
AxogenAXGN
$19.06M+30.1%
ICU Medical logo
ICU MedicalICUI
$316.63M-7.1%

Segments

By segment

See full
Medical Products & Therapies$781M+12.5%
Pharmaceuticals$458M+15.7%
Healthcare Systems & Technologies$390M+9.6%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Net sales$2,701$2,625
Cost of sales1,8101,764
Gross margin891861
Selling, general and administrative expenses728703
Research and development expenses139140
Other operating income, net(42)(40)
Operating income6658
Interest expense, net6664

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's total cost of revenue?
Baxter International (BAX) reported total cost of revenue of $1.81B in Q1 2026.
How has Baxter International's total cost of revenue changed year-over-year?
Baxter International's total cost of revenue increased by 2.6% year-over-year, from $1.76B to $1.81B.
What is the long-term trend for Baxter International's total cost of revenue?
Over 4 years (2021 to 2025), Baxter International's total cost of revenue has grown at a 1.4% compound annual growth rate (CAGR), from $7.43B to $7.87B.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about Baxter International's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude